Pre-Market Clinical Investigation Under EU MDR & ISO 14155:2020 Guide

Clinical Trial Operations

Navigate the complex landscape of pre-CE mark clinical investigations. Ensure Notified Body approval with meticulously designed protocols, EUDAMED integration, and full ISO 14155 compliance.

Consult our Clinical Experts

The transition from the Medical Device Directive (MDD) to the EU MDR 2017/745 fundamentally altered the path to market access. Reliance on literature reviews and strict equivalence is no longer sufficient for high-risk devices. Today, a robust premarket clinical study eu mdr is often the only viable route to obtain a CE mark.

The Four Regulatory Pillars of Pre-Market Studies

Executing a pre-ce mark clinical investigation requires strict adherence to multiple overlapping regulatory frameworks. Failure in any single pillar will result in rejection by Competent Authorities or Notified Bodies.

EU MDR Annex XV

Defines the strict legal requirements for clinical investigations in Europe, including protocol structures, investigator brochures, and sponsor obligations.

ISO 14155:2020

The core standard for Good Clinical Practice (GCP) specifically tailored for medical devices. It dictates how trials must be designed, conducted, and recorded.

GDPR Compliance

Stringent patient data protection laws requiring complete pseudonymization, explicit informed consent, and certified health data hosting (e.g., HDS in France).

Declaration of Helsinki

The ethical bedrock of human research. All clinical protocols must prioritize patient safety and well-being over scientific or commercial interests.

When is a Pre-Market Investigation Required?

Not all devices require a new clinical trial. The obligation to conduct a premarket study medical device eu mdr depends entirely on the device class and the availability of existing clinical data.

Device Class	Clinical Evidence Requirement	Is a Pre-Market Study Required?
Class I & IIa	Clinical evaluation based on literature, post-market data of equivalent devices, and bench testing.	Rarely. Only required if the device incorporates novel technology, materials, or an entirely new intended purpose with no equivalent on the market.
Class IIb	Comprehensive clinical evaluation report (CER). Equivalence claims are heavily scrutinized by Notified Bodies.	Frequently. Unless the manufacturer can prove strict equivalence (biological, technical, and clinical) to an existing device, a study is required.
Class III & Implantables	Exceptional clinical scrutiny. Article 61 strictly mandates clinical investigations for these high-risk categories.	Always Mandatory. Exceptions are extremely narrow (e.g., legacy devices undergoing MDR transition with highly robust existing clinical data).

Crucial Regulatory Update

EUDAMED Registration for Pre-Market Studies

As of recent regulatory updates and practical enforcement, managing a pre-market clinical investigation iso 14155 is inextricably linked to the EUDAMED database. Sponsors and Clinical Project Managers (CPMs) must navigate complex new administrative workflows before recruiting a single patient.

Single Registration Number (SRN): Sponsors must obtain an SRN to identify themselves across all EU regulatory documentation.
Investigation Registration: The Clinical Investigation Plan (CIP) and related documents must be formally registered in the EUDAMED Clinical Investigations and Performance Studies module.
Vigilance Reporting: All Serious Adverse Events (SAEs) and Device Deficiencies (DDs) that occur during the pre-market study must be reported centrally through EUDAMED, enforcing unprecedented transparency.

The Strategic Pathway to Market Access

Executing a clinical trial requires precise synchronization between clinical operations, data management, and regulatory affairs.

Our comprehensive approach to prospective clinical trials ensures that the data generated will directly satisfy the Notified Body's expectations during the Technical File review.

Protocol Design & Biostatistics: Aligning the primary endpoints directly with the General Safety and Performance Requirements (GSPRs) of Annex I.
Competent Authority & Ethics Submissions: Managing localized regulatory submissions across multiple European countries to ensure rapid site activation.
Clinical Data Management (EDC): Utilizing validated, 21 CFR Part 11 compliant Electronic Data Capture systems to ensure data integrity and real-time monitoring.
Clinical Evaluation Report (CER) Integration: The final Clinical Investigation Report (CIR) is seamlessly integrated into the overarching CER, providing the definitive proof of safety and performance.

Therapeutic Vertical Expertise

A successful pre-market study requires a CRO that understands the specific clinical environment and standard of care of your device.

Cardiovascular

Expertise in managing complex pre-market trials for Class III structural heart devices, navigating stringent VARC-3 criteria in specialized interventional settings.

Orthopaedics

Designing robust clinical investigations for joint replacements and spinal implants, focusing on long-term survivorship and functional patient-reported outcomes.

Wound Care

Executing pre-market studies for advanced matrices and active therapies, utilizing precise wound healing trajectory tracking per international guidelines.

Frequently Asked Questions

When is a premarket clinical study required under EU MDR?

Under Article 61 of the EU MDR 2017/745, a pre-market clinical investigation is strictly mandatory for all Class III devices and implantable devices, with very narrow exceptions (such as legacy devices undergoing transition with sufficient existing, high-quality clinical data or strict equivalence to an existing device).

How does ISO 14155:2020 impact pre-market studies?

ISO 14155:2020 defines the Good Clinical Practice (GCP) standards specifically for medical devices. It governs the design, conduct, recording, and reporting of the clinical investigation. Compliance with this standard ensures the clinical data is credible, reproducible, and that patient rights and safety are fully protected.

What are the EUDAMED requirements for pre-market studies?

Sponsors must obtain a Single Registration Number (SRN) and register the clinical investigation directly in the EUDAMED database. Furthermore, the regulation requires that all serious adverse events (SAEs) and device deficiencies observed during the trial be reported through EUDAMED.

Accelerate Your EU MDR Certification

Partner with a specialized Medical Device CRO to design and execute a pre-market clinical investigation that secures your CE mark without unnecessary delays or budget overruns.